Form 4 Filing for Abeona Therapeutics Inc.

Brendan O'Malley, SVP, Chief Legal Officer of Abeona Therapeutics Inc., reported the sale of 4,826 shares of Common Stock on June 8, 2026, for a weighted average price of $5.43 per share. On June 9, 2026, he reported the sale of 6,305 shares of Common Stock for a weighted average price of $5.30 per share. These sales were conducted to cover tax obligations associated with the vesting of restricted stock awards. Following these transactions, O'Malley directly owns 440,003 shares of Common Stock. The sales on June 8th and June 9th occurred at prices ranging from $5.345 to $5.54 and $5.24 to $5.47, respectively. Full details regarding the number of shares sold at each specific price within these ranges are available upon request.